Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Edgewise Therapeutics has the lowest figure of the 115 health care companies ranked by P/E ratio, at 4.9, followed by Universal Health Services (7.4) and Alnylam Pharmaceuticals (7.4). Figures as of 19 Nov 2026, 16:02 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- Lowest
- Edgewise Therapeutics4.9
- Median
- 30.2
- Combined market value
- SAR 33.51T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Edgewise TherapeuticsEWTX · Health Care | 4.9 | SAR 16.7B | SAR 152.74 | 1.57% down | 86% up | ||
| 2 | Universal Health ServicesUHS · Health Care | 7.4 | SAR 38.2B | SAR 662.24 | 5.12% down | 17% down | ||
| 3 | Alnylam PharmaceuticalsALNY · Health Care | 7.4 | SAR 74B | SAR 552.80 | 1.36% down | 66% down | ||
| 4 | Tenet HealthcareTHC · Health Care | 7.7 | SAR 78.5B | SAR 986.51 | 3.07% down | 45% up | ||
| 5 | CVS HealthCVS · Health Care | 9.3 | SAR 384B | SAR 300.12 | 1.65% down | 7% up | ||
| 6 | Novo NordiskNVO · Health Care | 9.8 | SAR 642.1B | SAR 145.69 | 1.50% down | 17% down | ||
| 7 | GrifolsGRFS · Health Care | 10.0 | SAR 21.2B | SAR 31.10 | 2.12% down | 0% up | ||
| 8 | Bio-Rad LaboratoriesBIO · Health Care | 10.1 | SAR 38.3B | SAR 1,423.75 | 2.54% up | 22% up | ||
| 9 | DaVitaDVA · Health Care | 11.6 | SAR 36.2B | SAR 575.07 | 5.24% down | 40% up | ||
| 10 | Fresenius Medical CareFMS · Health Care | 11.7 | SAR 39.3B | SAR 75.79 | 3.56% down | 7% down | ||
| 11 | Caris Life SciencesCAI · Health Care | 11.8 | SAR 21.1B | SAR 73.52 | 0.51% up | 19% down | ||
| 12 | Oscar HealthOSCR · Health Care | 11.9 | SAR 31.2B | SAR 100.30 | 3.01% down | 112% up | ||
| 13 | Cigna GroupCI · Health Care | 11.9 | SAR 267.8B | SAR 1,016.22 | 5.06% down | 6% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | 12.9 | SAR 447.6B | SAR 218.98 | 1.98% down | 30% up | ||
| 15 | ZoetisZTS · Health Care | 14.0 | SAR 125.5B | SAR 308.88 | 3.77% down | 26% down | ||
| 16 | HCA HealthcareHCA · Health Care | 15.3 | SAR 361.2B | SAR 1,728.99 | 3.24% down | 0% up | ||
| 17 | Elevance HealthELV · Health Care | 16.5 | SAR 314.5B | SAR 1,455.76 | 3.18% down | 28% up | ||
| 18 | GSKGSK · Health Care | 16.7 | SAR 359.5B | SAR 179.37 | 1.56% down | 5% up | ||
| 19 | Globus MedicalGMED · Health Care | 17.0 | SAR 34.4B | SAR 259.64 | 1.86% down | 14% down | ||
| 20 | GE HealthCare TechnologiesGEHC · Health Care | 17.4 | SAR 139.5B | SAR 308.59 | 1.66% down | 12% up | ||
| 21 | Ascendis PharmaASND · Health Care | 17.4 | SAR 65.2B | SAR 994.58 | 1.92% down | 29% up | ||
| 22 | Boston ScientificBSX · Health Care | 18.2 | SAR 235.1B | SAR 162.21 | 0.91% down | 55% down | ||
| 23 | CencoraCOR · Health Care | 18.9 | SAR 242.8B | SAR 1,272.58 | 2.60% down | 4% down | ||
| 24 | UnitedHealth GroupUNH · Health Care | 18.9 | SAR 1.11T | SAR 1,242.86 | 5.31% down | 12% up | ||
| 25 | ExelixisEXEL · Health Care | 19.6 | SAR 59.9B | SAR 245.52 | 4.15% down | 63% up | ||
| 26 | Smith & NephewSNN · Health Care | 20.3 | SAR 46.9B | SAR 112.17 | 1.37% down | 5% down | ||
| 27 | Regeneron PharmaceuticalsREGN · Health Care | 20.5 | SAR 360B | SAR 3,479.99 | 1.88% down | 28% up | ||
| 28 | Cooper CompaniesCOO · Health Care | 20.6 | SAR 42.7B | SAR 224.68 | 1.40% down | 15% down | ||
| 29 | Encompass HealthEHC · Health Care | 20.9 | SAR 48.1B | SAR 490.56 | 3.08% down | 20% up | ||
| 30 | United TherapeuticsUTHR · Health Care | 21.1 | SAR 89.2B | SAR 2,094.88 | 3.27% down | 22% up | ||
| 31 | ResMedRMD · Health Care | 21.5 | SAR 124.7B | SAR 886.44 | 2.59% down | 1% down | ||
| 32 | CenteneCNC · Health Care | 22.1 | SAR 119.6B | SAR 241.55 | 4.53% down | 94% up | ||
| 33 | InsuletPODD · Health Care | 22.3 | SAR 35.6B | SAR 512.69 | 2.36% down | 55% down | ||
| 34 | MSA SafetyMSA · Health Care | 22.7 | SAR 25.5B | SAR 662.58 | 0.46% down | 16% up | ||
| 35 | SanofiSNY · Health Care | 22.9 | SAR 414.5B | SAR 172.62 | 2.33% down | 4% down | ||
| 36 | Option Care HealthOPCH · Health Care | 22.9 | SAR 17.8B | SAR 118.63 | 0.27% down | 12% up | ||
| 37 | Halozyme TherapeuticsHALO · Health Care | 22.9 | SAR 39.2B | SAR 344.17 | 4.22% down | 39% up | ||
| 38 | Henry ScheinHSIC · Health Care | 23.0 | SAR 34.9B | SAR 315.52 | 1.84% down | 20% up | ||
| 39 | Neurocrine BiosciencesNBIX · Health Care | 23.5 | SAR 60.1B | SAR 593.71 | 2.81% down | 17% up | ||
| 40 | Align TechnologyALGN · Health Care | 23.5 | SAR 42.6B | SAR 604.74 | 1.67% down | 23% up | ||
| 41 | PACS GroupPACS · Health Care | 24.1 | SAR 25.3B | SAR 159.42 | 8.21% down | 77% up | ||
| 42 | Concentra Group Holdings ParentCON · Health Care | 24.3 | SAR 19.3B | SAR 153.79 | 2.19% down | 116% up | ||
| 43 | MedtronicMDT · Health Care | 24.6 | SAR 480.8B | SAR 375.91 | 0.50% down | 1% up | ||
| 44 | AstraZenecaAZN · Health Care | 24.7 | SAR 1.02T | SAR 655.64 | 2.22% down | 1% up | ||
| 45 | AmgenAMGN · Health Care | 25.3 | SAR 887.1B | SAR 1,640.05 | 1.50% down | 32% up | ||
| 46 | Lantheus HoldingsLNTH · Health Care | 25.4 | SAR 25B | SAR 382.77 | 0.04% up | 90% up | ||
| 47 | Koninklijke PhilipsPHG · Health Care | 25.6 | SAR 108.2B | SAR 110.64 | 1.06% down | 12% up | ||
| 48 | Quest DiagnosticsDGX · Health Care | 25.8 | SAR 107B | SAR 972.47 | 0.17% down | 38% up | ||
| 49 | Zimmer Biomet HoldingsZBH · Health Care | 26.0 | SAR 73.1B | SAR 386.24 | 0.34% down | 16% up | ||
| 50 | ChemedCHE · Health Care | 26.2 | SAR 26.6B | SAR 2,051.23 | 0.02% up | 27% up | ||
| 51 | LivaNovaLIVN · Health Care | 26.6 | SAR 19.2B | SAR 348.62 | 1.69% down | 77% up | ||
| 52 | Ensign GroupENSG · Health Care | 26.6 | SAR 39.2B | SAR 671.67 | 2.14% down | 2% up | ||
| 53 | Protagonist TherapeuticsPTGX · Health Care | 26.8 | SAR 31B | SAR 475.10 | 0.39% down | 51% up | ||
| 54 | QiagenQGEN · Health Care | 26.8 | SAR 38.4B | SAR 186.11 | 0.11% up | 9% up | ||
| 55 | McKessonMCK · Health Care | 27.0 | SAR 453.1B | SAR 3,924.82 | 3.51% down | 28% up | ||
| 56 | NovartisNVS · Health Care | 28.9 | SAR 1.07T | SAR 567.86 | 2.46% down | 25% up | ||
| 57 | STERISSTE · Health Care | 30.1 | SAR 92.5B | SAR 953.02 | 2.12% down | 1% up | ||
| 58 | Labcorp HoldingsLH · Health Care | 30.2 | SAR 112.3B | SAR 1,383.01 | 0.56% down | 42% up | ||
| 59 | AvantorAVTR · Health Care | 30.6 | SAR 38.8B | SAR 57.32 | 0.59% down | 40% up | ||
| 60 | IQVIA HoldingsIQV · Health Care | 31.0 | SAR 157.6B | SAR 956.20 | 1.13% down | 19% up | ||
| 61 | Merit Medical SystemsMMSI · Health Care | 31.6 | SAR 19B | SAR 316.51 | 1.80% down | 1% up | ||
| 62 | DexComDXCM · Health Care | 31.7 | SAR 112.8B | SAR 302.33 | 2.33% down | 41% up | ||
| 63 | argenxARGX · Health Care | 32.5 | SAR 221.3B | SAR 3,519.49 | 0.32% down | 2% up | ||
| 64 | StrykerSYK · Health Care | 33.4 | SAR 448.5B | SAR 1,178.15 | 1.28% down | 12% down | ||
| 65 | Vertex PharmaceuticalsVRTX · Health Care | 33.7 | SAR 498.2B | SAR 1,964.85 | 2.35% down | 27% up | ||
| 66 | HealthEquityHQY · Health Care | 34.7 | SAR 29.8B | SAR 360.40 | 1.26% down | 3% down | ||
| 67 | Agilent TechnologiesA · Health Care | 35.2 | SAR 188.6B | SAR 669.03 | 0.58% up | 22% up | ||
| 68 | Cardinal HealthCAH · Health Care | 35.2 | SAR 236.2B | SAR 1,021.88 | 2.12% down | 34% up | ||
| 69 | Medpace HoldingsMEDP · Health Care | 35.5 | SAR 67.1B | SAR 2,399.10 | 1.13% down | 10% up | ||
| 70 | IlluminaILMN · Health Care | 36.4 | SAR 119.8B | SAR 792.29 | 0.58% up | 76% up | ||
| 71 | Thermo Fisher ScientificTMO · Health Care | 36.7 | SAR 966B | SAR 2,607.06 | 0.33% up | 21% up | ||
| 72 | HumanaHUM · Health Care | 36.9 | SAR 170.5B | SAR 1,419.57 | 1.90% down | 73% up | ||
| 73 | Mettler-Toledo InternationalMTD · Health Care | 37.3 | SAR 128.2B | SAR 6,443.17 | 1.12% down | 24% up | ||
| 74 | DanaherDHR · Health Care | 37.7 | SAR 601.7B | SAR 855.27 | 0.25% down | 3% up | ||
| 75 | Abbott LaboratoriesABT · Health Care | 39.0 | SAR 679B | SAR 392.07 | 0.04% up | 16% down | ||
| 76 | PfizerPFE · Health Care | 39.5 | SAR 590.9B | SAR 103.68 | 1.50% down | 15% up | ||
| 77 | Johnson & JohnsonJNJ · Health Care | 40.3 | SAR 2.4T | SAR 995.38 | 2.69% down | 34% up | ||
| 78 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.2 | SAR 46.4B | SAR 55.66 | 0.93% down | 8% up | ||
| 79 | Becton, DickinsonBDX · Health Care | 41.9 | SAR 216.8B | SAR 795.85 | 1.81% down | 45% up | ||
| 80 | Krystal BiotechKRYS · Health Care | 42.4 | SAR 34.7B | SAR 1,170.39 | 1.05% down | 54% up | ||
| 81 | Eli LillyLLY · Health Care | 43.8 | SAR 4.51T | SAR 5,063.29 | 2.38% down | 33% up | ||
| 82 | GenmabGMAB · Health Care | 44.0 | SAR 119.1B | SAR 193.23 | 1.07% up | 70% up | ||
| 83 | Royalty PharmaRPRX · Health Care | 44.4 | SAR 146.6B | SAR 254.90 | 1.04% down | 79% up | ||
| 84 | West Pharmaceutical ServicesWST · Health Care | 44.8 | SAR 104.3B | SAR 1,497.92 | 1.16% down | 57% up | ||
| 85 | BrightSpring Health ServicesBTSG · Health Care | 45.9 | SAR 48.3B | SAR 242.88 | 5.25% down | 109% up | ||
| 86 | IDEXX LaboratoriesIDXX · Health Care | 46.5 | SAR 204B | SAR 2,589.71 | 1.15% down | 1% up | ||
| 87 | AbbVieABBV · Health Care | 48.2 | SAR 1.86T | SAR 1,053.06 | 1.84% down | 25% up | ||
| 88 | Corcept TherapeuticsCORT · Health Care | 49.1 | SAR 26.8B | SAR 245.17 | 3.58% down | 10% down | ||
| 89 | Intuitive SurgicalISRG · Health Care | 50.2 | SAR 540.1B | SAR 1,558.09 | 1.32% down | 24% down | ||
| 90 | BeOne MedicinesONC · Health Care | 51.4 | SAR 171.6B | SAR 1,502.61 | 0.75% down | 16% up | ||
| 91 | HaemoneticsHAE · Health Care | 53.1 | SAR 20.5B | SAR 449.82 | 2.39% down | 64% up | ||
| 92 | Amneal PharmaceuticalsAMRX · Health Care | 53.5 | SAR 28B | SAR 80.31 | 2.15% down | 90% up | ||
| 93 | AlconALC · Health Care | 55.2 | SAR 136.4B | SAR 283.88 | 0.56% up | 0% up | ||
| 94 | IncyteINCY · Health Care | 59.2 | SAR 88.7B | SAR 434.93 | 1.57% down | 16% up | ||
| 95 | Edwards LifesciencesEW · Health Care | 60.7 | SAR 225B | SAR 391.39 | 0.84% down | 25% up | ||
| 96 | Bio-TechneTECH · Health Care | 66.7 | SAR 42.8B | SAR 272.75 | 0.05% down | 24% up | ||
| 97 | HeartflowHTFL · Health Care | 67.4 | SAR 14.9B | SAR 169.26 | 1.67% down | 66% up | ||
| 98 | RevvityRVTY · Health Care | 68.9 | SAR 64.9B | SAR 581.59 | 1.72% up | 62% up | ||
| 99 | Jazz PharmaceuticalsJAZZ · Health Care | 70.8 | SAR 57.6B | SAR 898.03 | 3.37% down | 41% up | ||
| 100 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 71.7 | SAR 27.9B | SAR 354.92 | 0.45% down | 129% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/E ratio?
Edgewise Therapeutics (4.9), Universal Health Services (7.4) and Alnylam Pharmaceuticals (7.4) have the lowest P/E ratio of the 115 health care companies ranked here as of 19 Nov 2026, 16:02 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of SAR 33.51T as of 19 Nov 2026, 16:02 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.